Sign In

Michael Weintraub, MD

Clinical Assistant Professor of Medicine, Division of Endocrinology Diplomate of American Board of Obesity Medicine

Dr. Michael Weintraub is a highly accomplished professional with a diverse educational background and extensive experience in various healthcare and research organizations. He pursued a Bachelor of Science in Health Care Management from The Wharton School, a Bachelor of Arts in Biology, Pre-Med from University of Pennsylvania, and completed his Doctor of Medicine (MD) at Rutgers Robert Wood Johnson Medical School.

Highlights

Aug 29 · linkedin

GLP1 treatment was associated with a 77% lower risk of overall mortality compared to no treatment in those with obesity in a retrospective study

Aug 28 · linkedin

#Tirzepatide was associated with 48% decreased kidney events compared to #GLP1 RA, in a retrospective analysis of 140,308 patients with type 2 diabetes.

Also with: ⬇ 20% ❤️ MACE ⬇ 42% ☠ all cause mortality ⬇ 0.34% a1c ⬇ 2.9kg body weight

We need full randomized clinical trials before we can make conclusions of clear superiority

https://lnkd.in/e2XeKzfe

Michael Weintraub, MD
Add to my network

Location

New York, New York, United States